160 related articles for article (PubMed ID: 24460324)
21. Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma.
Stenman M; Laurell A; Lindskog M
Med Oncol; 2014 Mar; 31(3):841. PubMed ID: 24477648
[TBL] [Abstract][Full Text] [Related]
22. Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience.
Kondo T; Ikezawa E; Takagi T; Kobayashi H; Hashimoto Y; Iizuka J; Omae K; Yoshida K; Tanabe K
Int J Urol; 2013 Nov; 20(11):1072-7. PubMed ID: 23421632
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of renal cancer in Malaysia : a ten year review.
Singam P; Ho C; Hong GE; Mohd A; Tamil AM; Cheok LB; Zainuddin Z
Asian Pac J Cancer Prev; 2010; 11(2):503-6. PubMed ID: 20843141
[TBL] [Abstract][Full Text] [Related]
24. Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival.
Szendroi A; Tabák A; Riesz P; Szucs M; Nyírády P; Majoros A; Haas G; Romics I
Int Urol Nephrol; 2009 Dec; 41(4):835-42. PubMed ID: 19283507
[TBL] [Abstract][Full Text] [Related]
25. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
[TBL] [Abstract][Full Text] [Related]
28. Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
Urol Oncol; 2016 Oct; 34(10):433.e1-8. PubMed ID: 27321354
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of thrombocytosis in renal cell carcinoma.
Bensalah K; Leray E; Fergelot P; Rioux-Leclercq N; Tostain J; Guillé F; Patard JJ
J Urol; 2006 Mar; 175(3 Pt 1):859-63. PubMed ID: 16469566
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma.
Chang YH; Chuang CK; Pang ST; Wu CT; Chuang KL; Chuang HC; Liao SK
Kaohsiung J Med Sci; 2011 Feb; 27(2):59-63. PubMed ID: 21354519
[TBL] [Abstract][Full Text] [Related]
31. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases.
Qi N; Chen Y; Gong K; Li H
World J Surg Oncol; 2018 Jan; 16(1):16. PubMed ID: 29370814
[TBL] [Abstract][Full Text] [Related]
32. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
[TBL] [Abstract][Full Text] [Related]
33. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.
Kuczyk M; Wegener G; Merseburger AS; Anastasiadis A; Machtens S; Zumbrägel A; Hartmann JT; Bokemeyer C; Jonas U; Stenzl A
World J Urol; 2005 Feb; 23(1):50-4. PubMed ID: 15729558
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma].
Breyer J; Otto W; Lausenmeyer EM; Denzinger S; Schwientek AK; Ochs L; Mayr R; Gierth M; Bründl J; Burger M; Evert M; Fritsche HM; Eichelberg C
Aktuelle Urol; 2017 May; 48(3):230-237. PubMed ID: 28423432
[No Abstract] [Full Text] [Related]
36. [Renal cell carcinoma before the age of 40: prognostic factors].
Moudouni S; En-Nia I; Rioux-Leclerq N; Bensalah K; Guille F; Lobel B; Patard JJ
Prog Urol; 2002 Sep; 12(4):575-8. PubMed ID: 12463113
[TBL] [Abstract][Full Text] [Related]
37. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
[TBL] [Abstract][Full Text] [Related]
39. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Jung K
Cancer Sci; 2008 Jun; 99(6):1188-94. PubMed ID: 18422740
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
